PA9159 nasal spray solution, 80 μg one day treatment

DRUG2 trials

Sponsors

Anhui Palo Alto Pharmaceuticals, Inc.

Conditions

Allergic Rhinitis

Phase 1

Safety, Tolerability, and Pharmacokinetics of PA9159 Nasal Spray in Healthy Adult Subjects

CompletedNCT05170763

Anhui Palo Alto Pharmaceuticals, Inc.Allergic Rhinitis

Start: 2021-11-10End: 2022-01-05Updated: 2022-01-19

Study on the Safety, Tolerability, and Pharmacokinetics of PA9159 Nasal Spray in Healthy Adult Subjects

CompletedNCT07345442

Anhui Palo Alto Pharmaceuticals, Inc.Allergic Rhinitis

Start: 2025-03-14End: 2025-06-09Updated: 2026-01-15